Read the Latest News

National Academy of Medicine Study on Temporomandibular Disorders

The first meeting of the National Academy of Medicine Committee on Temporomandibular Disorders (TMD): From Research Discoveries to Clinical Treatment will be held Tuesday, January 29, 2019 at the National Academy of Sciences building in Washington, D.C.&

Attention Canadian TMJ Implant Patients

The Trial of the Class Action brought by Canadian patients who were implanted with Vitek Proplast TMJ implants, against Health Canada, alleging negligent regulation starts on April 1, 2019 in Toronto.

Long-term Changes in Biopsychosocial Characteristics Related to Temporomandibular Disorder: Findings from the OPPERA Study

The following article by Roger B. Fillingim, Gary D. Slade, Joel D. Greenspan, Ronald Dubner, William Maixner, Eric Bair, and Richard Ohrbach was published in the journal of Pain, November 2018. We are grateful to Dr. Fillingim for writing the following

National Academy of Medicine to Conduct a Study on Temporomandibular Disorders

We want you to be among the first to know that because of the advocacy efforts of The TMJ Association, the National Academy of Medicine (NAM) will conduct a first-ever study on Temporomandibular Disorders (TMD).

Dentists in Distress

Fear of the dentist is practically a rite of passage in youth. Growing up, I wasn't exactly afraid of the dentist; rather, any excuse to leave school early was a powerful incentive. These days, I have a more complicated relationship with dentistry: I go to get answers and try to feel better, but I always pop a prophylactic ibuprofen or two in case my jaw protests from the oral gymnastics.

Funding Opportunities now available for the NIH Common Fund’s Acute to Chronic Pain Signatures program

  • Aug 29, 2018

The NIH Common Fund’s Acute to Chronic Pain Signatures program aims to understand the biological characteristics underlying the transition from acute to chronic pain and what makes some people susceptible and others resilient to the development of chronic pain. A2CPS is part of the NIH-wide HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-NIH effort to speed scientific solutions to stem the national opioid public health crisis. 

Summary:  The A2CPS program will collect data from: (1) patients with acute pain associated with a surgical procedure and (2) patients with acute pain from a musculoskeletal trauma such as a broken bone. Neuroimaging, high-throughput biomedical measurements, sensory testing, and psychosocial assessments collected periodically after the acute pain event will form a comprehensive data set to help predict which patients will develop long-lasting chronic pain. The goal of these studies is to identify individual patient features that together, will provide clinically meaningful, predictive “signatures” of transition or resilience to chronic pain.

The NIH is inviting applications for five funding opportunities: 

Applications are due October 24, 2018.

An informational webinar will be held on September 6th, 2018 from 2-4 PM, EST. 

Join us via WebEx using this link

Call-in toll number (US/Canada): 1-650-479-3208

Event number: 624 155 354

Event password: PainSig

For additional information about the A2CPS program, please visit https://commonfund.nih.gov/pain and contact:

Linda L. Porter, Ph.D.  (RFA-RM-18-033, RFA-RM-18-034, RFA-RM-18-035)

National Institute on Neurological Disorders and Stroke (NINDS)

Telephone: 301-435-7572

Email: porterl@ninds.nih.gov

John Satterlee, Ph.D.  (RFA-RM-18-031, RFA-RM-18-032)

National Institute on Drug Abuse (NIDA)

Telephone: 301-435-1020

Email:  satterleej@nida.nih.gov

The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.  

The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.

TMJ Disorders

Comments:

Login or Register to add Comment